Buscar
Mostrando ítems 1-10 de 45
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1
(Blackwell Publishing, 2006-08-01)
Peginterferon-alpha plus ribavirin is the most effective therapy for chronic hepatitis C. This study was designed to evaluate the effect of peginterferon alpha-2a (40 kDa) plus ribavirin on sustained virological response ...
Retreatment of hepatitis C patients who previously experienced treatment failure
(ContextoSalvadorBrasil, 2007)
Resultados del tratamiento con peginterferón alfa-2a y ribavirina en pacientes con hepatitis crónica C
(Sociedad Médica de Santiago, 2011)
Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin
(Blackwell PublishingOxfordInglaterra, 2006)
Hepatitis B virus surface antigen seroconversion in HIV-infected individual after pegylated interferon-alpha treatment: a case report
(Biomed Central LtdLondonInglaterra, 2013)
Resultados del tratamiento de la hepatitis crónica por virus C en un hospital público, en Chile
(2012)
Background: Chronic hepatitis C is an important health problem in Chile. In
2005, the Ministry of Health started a pilot treatment program with peg interferon
and ribavirin, to be developed in public hospitals all over ...